EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62021TB0267
Case T-267/21: Order of the General Court of 9 November 2021 — Amort and Others v Commission (Action for annulment — Medicinal products for human use — Conditional marketing authorisation for the medicinal product for human use ‘COVID-19 Vaccine Janssen — COVID-19 vaccine (Ad26.COV2-S [recombinant])’ — No interest in bringing proceedings — Lack of direct concern — Lack of individual concern — Non-regulatory act — Inadmissibility)
Case T-267/21: Order of the General Court of 9 November 2021 — Amort and Others v Commission (Action for annulment — Medicinal products for human use — Conditional marketing authorisation for the medicinal product for human use ‘COVID-19 Vaccine Janssen — COVID-19 vaccine (Ad26.COV2-S [recombinant])’ — No interest in bringing proceedings — Lack of direct concern — Lack of individual concern — Non-regulatory act — Inadmissibility)
Case T-267/21: Order of the General Court of 9 November 2021 — Amort and Others v Commission (Action for annulment — Medicinal products for human use — Conditional marketing authorisation for the medicinal product for human use ‘COVID-19 Vaccine Janssen — COVID-19 vaccine (Ad26.COV2-S [recombinant])’ — No interest in bringing proceedings — Lack of direct concern — Lack of individual concern — Non-regulatory act — Inadmissibility)
OJ C 24, 17.1.2022, p. 42–42
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
17.1.2022 |
EN |
Official Journal of the European Union |
C 24/42 |
Order of the General Court of 9 November 2021 — Amort and Others v Commission
(Case T-267/21) (1)
(Action for annulment - Medicinal products for human use - Conditional marketing authorisation for the medicinal product for human use ‘COVID-19 Vaccine Janssen — COVID-19 vaccine (Ad26.COV2-S [recombinant])’ - No interest in bringing proceedings - Lack of direct concern - Lack of individual concern - Non-regulatory act - Inadmissibility)
(2022/C 24/55)
Language of the case: German
Parties
Applicants: Heidi Amort (Jenesien, Italy) and the 22 other applicants whose names are set out in the annex to the order (represented by: R. Holzeisen, lawyer)
Defendant: European Commission (represented by: B.-R. Killmann and A. Sipos, acting as Agents)
Re:
Application under Article 263 TFEU for annulment of Commission Implementing Decision C(2021) 1763 (final) of 11 March 2021 granting a conditional marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for ‘COVID-19 Vaccine Janssen — COVID-19 vaccine (Ad26.COV2-S [recombinant])’, a medicinal product for human use, as amended and supplemented.
Operative part of the order
|
1. |
The action is dismissed as inadmissible. |
|
2. |
There is no longer any need to adjudicate on the applications for leave to intervene submitted by TF, TG, TH and TI, by TR and the other persons whose names are set out in Annex II and by VH and the other persons whose names are set out in Annex II. |
|
3. |
Ms Heidi Amort and the other persons whose names are set out in Annex I shall pay the costs. |
|
4. |
TF, TG, TH and TI, TR and the other persons whose names are set out in Annex II and VH and the other persons whose names are set out in Annex II shall each bear their own costs relating to the applications for leave to intervene. |